Valeant Interim CEO Schiller to Be Paid $400,000 a Month
- Schiller has an initial two-month contract, could be extended
- Company scheduled to appear at congressional hearing Thursday
Howard Schiller.
Photographer: Andrew Harrer/BloombergThis article is for subscribers only.
Valeant Pharmaceuticals International Inc.’s interim Chief Executive Officer Howard Schiller will be paid $400,000 a month while CEO Michael Pearson recovers from severe pneumonia, the drugmaker said Tuesday.
Schiller started the temporary CEO job on Jan. 6 and will be paid the rate for two months, Valeant said in a regulatory filing.